Snehjeev Ventures and PACs cross 11% stake in Amerise Biosciences via open market
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.4 pts less than Nifty Microcap 250 and 0.3 pts more than its Plastic Products - Industrial peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Snehjeev Ventures Pvt Ltd and PACs (Rushank, Sneha, Riddhi, and Sanjeev Lunkad) disclosed acquisition of 76,725 equity shares (0.12%) of Amerise Biosciences through open market on 14 Aug 2026. Total holding now stands at 72,92,684 shares (11.04%), up from 10.92% earlier. The acquirer is not part of the promoter group, making this an external creeping acquisition past the 11% threshold. Equity share capital is 66,06,900 shares of Rs 10 each.
External acquirer crossing 11% via creeping buy may signal takeover interest; could trigger open offer obligations if 25% threshold is crossed.